메뉴 건너뛰기
Antimicrobial Agents and Chemotherapy
Volumn 58, Issue 4, 2014, Pages 2426-2429
Overexpression of MexCD-OprJ reduces pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing
Author keywords

[No Author keywords available]
Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3;
EID: 84896987890     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02012-13     Document Type: Article
Times cited : (23)
References (27)
  • 1
    • 0038177618 scopus 로고    scopus 로고
    • Nosocomial infections in adult intensive-care units
    • Vincent JL. 2003. Nosocomial infections in adult intensive-care units. Lancet 361:2068-2077. http://dx.doi.org/10.1016/S0140-6736(03)13644-6.
    • (2003) Lancet , vol.361 , pp. 2068-2077
    • Vincent, J.L.1
  • 2
    • 0036225688 scopus 로고    scopus 로고
    • Lung infections associated with cystic fibrosis
    • DOI 10.1128/CMR.15.2.194-222.2002
    • Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222. http://dx.doi.org/10.1128/ CMR.15.2.194-222.2002. (Pubitemid 34303763)
    • (2002) Clinical Microbiology Reviews , vol.15 , Issue.2 , pp. 194-222
    • Lyczak, J.B.1    Cannon, C.L.2    Pier, G.B.3
  • 3
    • 0029761031 scopus 로고    scopus 로고
    • Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa
    • Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. 1996. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur. Respir. J. 9:1601-1604. http://dx.doi.org/10.1183/09031936.96.09081601. (Pubitemid 26271139)
    • (1996) European Respiratory Journal , vol.9 , Issue.8 , pp. 1601-1604
    • Evans, S.A.1    Turner, S.M.2    Bosch, B.J.3    Hardy, C.C.4    Woodhead, M.A.5
  • 4
    • 70449124604 scopus 로고    scopus 로고
    • Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms
    • Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610. http://dx.doi.org/10.1128/CMR.00040-09.
    • (2009) Clin. Microbiol. Rev. , vol.22 , pp. 582-610
    • Lister, P.D.1    Wolter, D.J.2    Hanson, N.D.3
  • 5
    • 0036498656 scopus 로고    scopus 로고
    • Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
    • DOI 10.1086/338782
    • Livermore DM. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640. http://dx.doi.org/10.1086/338782. (Pubitemid 34165326)
    • (2002) Clinical Infectious Diseases , vol.34 , Issue.5 , pp. 634-640
    • Livermore, D.M.1
  • 6
    • 1642422948 scopus 로고    scopus 로고
    • Efflux-mediated multiresistance in Gram-negative bacteria
    • DOI 10.1111/j.1469-0691.2004.00763.x
    • Poole K. 2004. Efflux mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10:12-26. http://dx.doi.org/10.1111/j.1469-0691.2004. 00763.x. (Pubitemid 38128588)
    • (2004) Clinical Microbiology and Infection , vol.10 , Issue.1 , pp. 12-26
    • Poole, K.1
  • 8
    • 84864386394 scopus 로고    scopus 로고
    • Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks
    • Olivares J, Álvarez-Ortega C, Linares JF, Rojo F, Köhler T, Martínez JL. 2012. Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks. Environ. Microbiol. 14:1968-1981. http://dx.doi.org/10.1111/j.1462-2920.2012.02727.x.
    • (2012) Environ. Microbiol. , vol.14 , pp. 1968-1981
    • Olivares, J.1    Álvarez-Ortega, C.2    Linares, J.F.3    Rojo, F.4    Köhler, T.5    Martínez, J.L.6
  • 11
    • 79956023809 scopus 로고    scopus 로고
    • Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa
    • Abdelraouf K, Kabbara S, Ledesma KR, Poole K, Tam VH. 2011. Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 66:1311-1317. http://dx.doi.org/10.1093/jac/dkr105.
    • (2011) J. Antimicrob. Chemother. , vol.66 , pp. 1311-1317
    • Abdelraouf, K.1    Kabbara, S.2    Ledesma, K.R.3    Poole, K.4    Tam, V.H.5
  • 12
    • 2142761564 scopus 로고    scopus 로고
    • The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response against Pseudomonas aeruginosa in a Murine Model of Pneumonia
    • DOI 10.1128/IAI.72.5.2899-2906.2004
    • Mueller-Ortiz SL, Drouin SM, Wetsel RA. 2004. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect. Immun. 72:2899-2906. http://dx.doi.org/10.1128/IAI.72.5.2899-2906.2004. (Pubitemid 38542420)
    • (2004) Infection and Immunity , vol.72 , Issue.5 , pp. 2899-2906
    • Mueller-Ortiz, S.L.1    Drouin, S.M.2    Wetsel, R.A.3
  • 14
    • 77149179342 scopus 로고    scopus 로고
    • Activity of a new cephalosporin, CXA-101 (FR264205), against β-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients
    • Moya B, Zamorano L, Juan C, Pérez JL, Ge Y, Oliver A. 2010. Activity of a new cephalosporin, CXA-101 (FR264205), against β-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients. Antimicrob. Agents Chemother. 54:1213-1217. http://dx.doi.org/10.1128/AAC.01104-09.
    • (2010) Antimicrob. Agents Chemother. , vol.54 , pp. 1213-1217
    • Moya, B.1    Zamorano, L.2    Juan, C.3    Pérez, J.L.4    Ge, Y.5    Oliver, A.6
  • 15
    • 63449128597 scopus 로고    scopus 로고
    • β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
    • Moya B, Dötsch A, Juan C, Blázquez J, Zamorano L, Haussler S, Oliver A. 2009. β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 5:e1000353. http://dx.doi.org/10.1371/journal.ppat.1000353.
    • (2009) PLoS Pathog , vol.5
    • Moya, B.1    Dötsch, A.2    Juan, C.3    Blázquez, J.4    Zamorano, L.5    Haussler, S.6    Oliver, A.7
  • 16
    • 54049144292 scopus 로고    scopus 로고
    • Benefit of having multiple ampD genes for acquiring β-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa
    • Moya B, Juan C, Alberti S, Perez JL, Oliver A. 2008. Benefit of having multiple ampD genes for acquiring β-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:3694-3700. http://dx.doi.org/10.1128/AAC.00172-08.
    • (2008) Antimicrob. Agents Chemother. , vol.52 , pp. 3694-3700
    • Moya, B.1    Juan, C.2    Alberti, S.3    Perez, J.L.4    Oliver, A.5
  • 17
    • 65649106230 scopus 로고    scopus 로고
    • Azithromycin in Pseudomonas aeruginosa biofilms: Bactericidal activity and selection of nfxB mutants
    • Mulet X, Maciá MD, Mena A, Juan C, Pérez JL, Oliver A. 2009. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. Antimicrob. Agents Chemother. 53:1552-1560. http://dx.doi.org/10.1128/AAC.01264-08.
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 1552-1560
    • Mulet, X.1    Maciá, M.D.2    Mena, A.3    Juan, C.4    Pérez, J.L.5    Oliver, A.6
  • 18
    • 80052845657 scopus 로고    scopus 로고
    • Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth
    • Mulet X, Moyá B, Juan C, Macià MD, Pérez JL, Blázquez J, Oliver A. 2011. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. Antimicrob. Agents Chemother. 55:4560-4568. http://dx.doi.org/10.1128/ AAC.00519-11.
    • (2011) Antimicrob. Agents Chemother. , vol.55 , pp. 4560-4568
    • Mulet, X.1    Moyá, B.2    Juan, C.3    Macià, M.D.4    Pérez, J.L.5    Blázquez, J.6    Oliver, A.7
  • 19
    • 1342281320 scopus 로고    scopus 로고
    • C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells
    • de Astorza B, Cortés G, Crespí C, Saus C, Rojo JM, Albertí S. 2004. C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells. Infect. Immun. 72:1767-1774. http://dx.doi.org/10.1128/IAI.72. 3.1767-1774.2004.
    • (2004) Infect. Immun. , vol.72 , pp. 1767-1774
    • De Astorza, B.1    Cortés, G.2    Crespí, C.3    Saus, C.4    Rojo, J.M.5    Albertí, S.6
  • 20
    • 77954596827 scopus 로고    scopus 로고
    • Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa
    • Stickland HG, Davenport PW, Lilley KS, Griffin JL, Welch M. 2010. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa. J. Proteome Res. 9:2957-2966. http://dx.doi.org/10.1021/ pr9011415.
    • (2010) J. Proteome Res. , vol.9 , pp. 2957-2966
    • Stickland, H.G.1    Davenport, P.W.2    Lilley, K.S.3    Griffin, J.L.4    Welch, M.5
  • 21
    • 0026490125 scopus 로고
    • Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa
    • Jakics EB, Iyobe S, Hirai K, Fukuda H, Hashimoto H. 1992. Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2562-2565. http://dx.doi.org/10.1128/AAC.36.11. 2562.
    • (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 2562-2565
    • Jakics, E.B.1    Iyobe, S.2    Hirai, K.3    Fukuda, H.4    Hashimoto, H.5
  • 22
    • 0028303739 scopus 로고
    • Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa
    • Yoshida T, Muratani T, Iyobe S, Mitsuhashi S. 1994. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38:1466-1469. http://dx.doi.org/10. 1128/AAC.38.7.1466. (Pubitemid 24203553)
    • (1994) Antimicrobial Agents and Chemotherapy , vol.38 , Issue.7 , pp. 1466-1469
    • Yoshida, T.1    Muratani, T.2    Iyobe, S.3    Mitsuhashi, S.4
  • 23
    • 46249116233 scopus 로고    scopus 로고
    • Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump
    • DOI 10.1128/AAC.01107-07
    • Jeannot K, Elsen S, Köhler T, Attree I, van Delden C, Plésiat P. 2008. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob. Agents Chemother. 52:2455-2462. http://dx.doi.org/10.1128/AAC.01107-07. (Pubitemid 351915675)
    • (2008) Antimicrobial Agents and Chemotherapy , vol.52 , Issue.7 , pp. 2455-2462
    • Jeannot, K.1    Elsen, S.2    Kohler, T.3    Attree, I.4    Van Delden, C.5    Plesiat, P.6
  • 24
    • 34247092332 scopus 로고    scopus 로고
    • Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: A longitudinal observation in mechanically ventilated patients
    • DOI 10.1128/AAC.01278-06
    • Reinhardt A, Köhler T, Wood P, Rohner P, Dumas JL, Ricou B, van Delden C. 2007. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients. Antimicrob. Agents Chemother. 51:1341-1350. http://dx.doi.org/10.1128/ AAC.01278-06. (Pubitemid 46586815)
    • (2007) Antimicrobial Agents and Chemotherapy , vol.51 , Issue.4 , pp. 1341-1350
    • Reinhardt, A.1    Kohler, T.2    Wood, P.3    Rohner, P.4    Dumas, J.-L.5    Ricou, B.6    Van Delden, C.7
  • 25
    • 0033999155 scopus 로고    scopus 로고
    • Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    • DOI 10.1128/AAC.44.3.710-712.2000
    • Jalal S, Ciofu O, Høiby N, Gotoh N, Wretlind B. 2000. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 44:710-712. http://dx.doi.org/10.1128/AAC.44.3.710-712.2000. (Pubitemid 30117966)
    • (2000) Antimicrobial Agents and Chemotherapy , vol.44 , Issue.3 , pp. 710-712
    • Jalal, S.1    Ciofu, O.2    Hoiby, N.3    Gotoh, N.4    Wretlind, B.5
  • 26
    • 77954645140 scopus 로고    scopus 로고
    • Early adaptive developments of Pseudomonas aeruginosa after transition from the life in the environment to persistent colonization in the airways of human cystic fibrosis hosts
    • Rau MH, Hansen SK, Johansen HK, Thomsen LE, Workman CT, Nielsen KF, Jelsbak L, Høiby N, Yang L, Molin S. 2010. Early adaptive developments of Pseudomonas aeruginosa after transition from the life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ. Microbiol. 12:1643-1648.
    • (2010) Environ. Microbiol. , vol.12 , pp. 1643-1648
    • Rau, M.H.1    Hansen, S.K.2    Johansen, H.K.3    Thomsen, L.E.4    Workman, C.T.5    Nielsen, K.F.6    Jelsbak, L.7    Høiby, N.8    Yang, L.9    Molin, S.10

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.